Related Experiment Videos

Purification and partial characterization of a product from Yersinia pseudotuberculosis with the ability to activate

T Miyoshi-Akiyama1, K Imanishi, T Uchiyama

  • 1Department of Microbiology and Immunology, Tokyo Women's Medical College, Japan.

Infection and Immunity
|September 1, 1993
PubMed

Insights

Researchers purified a novel Yersinia pseudotuberculosis-derived mitogen (YPM) that stimulates human T cells. This YPM enhances T-cell proliferation and interleukin-2 production, requiring HLA class II expression on accessory cells for activation.

Area of Science:

  • Immunology
  • Microbiology
  • Biochemistry

Background:

  • Yersinia pseudotuberculosis infections can cause severe systemic symptoms.
  • Understanding bacterial components that modulate host immune responses is crucial.

Purpose of the Study:

  • To isolate and characterize a mitogenic substance from Yersinia pseudotuberculosis.
  • To investigate the immunomodulatory effects of the purified substance on human lymphocytes.

Main Methods:

  • Bacterial sonication and supernatant collection.
  • Sequential chromatography using DEAE-Sepharose, Sephacryl S-100 HR, and TSK-gel G2000SW.
  • SDS-PAGE for molecular mass determination.
  • Assays for T-cell proliferation and IL-2 production.

Main Results:

  • A single mitogenically active substance, YPM, was purified.
  • YPM has a molecular mass of 21 kDa.
  • YPM stimulates human T-cell proliferation and IL-2 production at low concentrations (≥0.1 ng/ml).
  • YPM-induced T-cell activation is dependent on HLA class II expression on accessory cells.

Conclusions:

  • Yersinia pseudotuberculosis produces a potent mitogen, YPM.
  • YPM is a valuable tool for studying T-cell activation and immune responses.
  • The findings highlight YPM's role in Yersinia pathogenesis and immune evasion strategies.

Related Concept Videos